| |
| |
|
| Insider
Information: |
Gray Mary Ann |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
254,396 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,146,125 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
254,396 |
|
|
| Total
Value |
$4,146,125 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mabvax Therapeutics Holdings Inc |
MBVX |
Director |
2005-03-16 |
5,000 |
2005-03-16 |
0 |
Premium* |
|
|
GTC Biotherapeutics Inc |
GTCB |
Director |
2007-12-17 |
11,000 |
|
0 |
Premium* |
|
|
Acadia Pharmaceuticals Inc |
ACAD |
|
2016-06-07 |
149,476 |
2013-08-26 |
0 |
Premium* |
|
|
Juniper Pharmaceuticals Inc |
JNP |
Director |
2018-08-14 |
0 |
2016-04-05 |
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
39,167 |
|
0 |
Premium* |
|
|
Senomyx Inc |
SNMX |
Director |
2018-11-02 |
0 |
2017-03-24 |
0 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2022-03-07 |
12,356 |
2019-03-04 |
0 |
Premium* |
|
|
Bioatla, Inc. |
BCAB |
Director |
2023-12-31 |
37,397 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,995 |
37,397 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,676 |
31,402 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,916 |
22,726 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,503 |
17,810 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,953 |
12,356 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2021-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
967 |
9,403 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,726 |
8,436 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2020-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,307 |
|
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2020-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
967 |
5,710 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,075 |
4,743 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2019-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
967 |
2,668 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,633 |
1,701 |
0 |
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2018-11-02 |
4 |
D |
$1.50 |
$15,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2018-08-14 |
4 |
D |
$11.50 |
$186,806 |
D/D |
(16,244) |
0 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2017-10-10 |
4 |
A |
$0.38 |
$5,879 |
D/D |
15,472 |
39,167 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2017-07-06 |
4 |
A |
$0.59 |
$5,821 |
D/D |
9,866 |
23,695 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2017-04-10 |
4 |
A |
$0.59 |
$5,201 |
D/D |
8,815 |
13,829 |
0 |
- |
|
| SNMX |
Senomyx Inc |
Director |
• • – |
2017-03-24 |
4 |
B |
$1.00 |
$10,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2017-01-20 |
4 |
A |
$1.98 |
$5,000 |
D/D |
2,525 |
5,004 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2016-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,064 |
7,334 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2016-06-07 |
4 |
OE |
$9.04 |
$150,398 |
D/D |
16,637 |
149,476 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2016-04-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
39,938 |
|
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2016-04-07 |
4 |
OE |
$1.30 |
$176,600 |
D/D |
132,839 |
132,839 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2016-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,270 |
1,270 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2015-01-13 |
4 |
OE |
$11.00 |
$46,750 |
D/D |
4,250 |
4,250 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
